What We're Reading: Page 184
Industry reads hand-picked by our editors
Mar 04, 2021
-
STAT
Kronos Bio speeds development of genetically targeted leukemia drug
-
The Wall Street Journal
Mount Sinai Leases Space for Biotech Campus on Manhattan’s West Side
-
In the Pipeline
How to Administer RNA – And How to Do It Again
-
The New York Times
India's Covaxin Covid-19 Vaccine, Already in Use, Shows Promise in Trials
Mar 03, 2021
Mar 02, 2021
-
Chemical & Engineering News
The fight against fungi
-
The Wall Street Journal
Covid-19 Vaccines Yield Breakthroughs in Long-Term Fight Against Infectious Disease
-
Evaluate Vantage
Early Morphic data hint at a threat to Entyvio
-
Science
New immunotherapy drugs target two evasive cancer-driving proteins
Mar 01, 2021
Feb 26, 2021
Feb 25, 2021
-
BioCentury
Democratic opposition could sink Woodcock’s chances to be nominated as permanent FDA commissioner
-
STAT
GSK's Covid-19 drug falls short in trial, but may benefit older patients
-
Boston Business Journal
Cellarity, Flagship startup that aims to treat 'any disease,' raises $123M
-
Reuters
Regeneron to stop giving placebo in COVID-19 drug trial after 'clear efficacy'
Previous
